2023 ESMO Highlights Webinar
Webinar | English | 60 Min
Image For Activity Cover
Credit Offered
1 ACCME Credit
1 Certificate of Attendance Credit
IASLC’s Education Committee presents a one-hour session, synthesizing lung cancer research presented at the recent October meeting of the European Society for Medical Oncology (ESMO) 2023 Congress. This webinar will address clinicians’ need to keep abreast of current research and future trends to inform clinical practice.
Live Activity Date: November 15, 2023
Enduring Activity Launch Date: December 19, 2023
Enduring Activity Expiration Date:Decenber 18, 2024
Physicians and researchers.
Upon completion of this activity, the participants should be able to: 
  • Recognize new data to the changing NSCLC early-stage scenario.
  • Analyze targeted therapies to determine a new standard of care.
  • Evaluate the role of new drugs with different mechanisms of action and new toxicities.
  • Pilar Garrido, MD, PhD, Head Medical Oncology Hospital, Universitario Ramón y Cajal, Spain 
  • Helena Linardou, MD, PhD, Director, 4th Oncology Department, Metropolitan Hospital, Greece 
  • Bartomeu Massuti, MD, Medical Oncologist/Associate Professor Alicante University Hospital, Universidad Miguel Hernandez De Elche, Spain
  • Telma Sequeira, MD, MSc, Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E, Portugal
The following planners, speakers, reviewers, or staff have relevant financial relationships to disclose: 

Full Legal Name Commercial Interest Role Level of Participation in the Activity
Pilar Garrido AbbVie, Inc. Advisor Planner/speaker
  Amgen Advisor  
  AstraZeneca Advisor  
  Bayer Advisor  
  BMS Advisor  
  Daiichi Sankyo Advisor  
  GSK Advisor  
  Janssen Advisor  
  Novartis Advisor  
  Roche Advisor  
  Sanofi Advisor  
  MSD Advisor Planner
Bartomeu Massuti Roche Speaker  
  Bristol Myers Squibb Speaker, Research funding  
  Boehringer Advisor  
  AstraZeneca Advisor  
Telma Sequeira Amgen Advisor  
  Bristol Myers Squibb Speaker  
  Janssen Cilag Speaker  
  Pierre Fabre Advisor  
  MSD Advisor  
  Takeda Advisor  
  Daiichi Sankyo Speaker Speaker
  Pfizer Speaker  
  AstraZeneca Speaker  
  Sanofi Speaker  
Helena Linardou Amgen Speaker Speaker
  AstraZeneca Speaker  
  Bristol Myers Squibb Speaker, Advisor  
  GSK Advisor  
  Lilly Advisor  
  Merck Advisor  
  MSD Speaker, Advisor  
  Norvartis Speaker Speaker
  Pfizer Speaker  
  Roche Advisor  

"I have at present or have had within the last 24 months, a financial relationship with one or more ineligible companies."

These relationships with ineligible companies have been mitigated by the International Association for the Stufy of Lung Cancer (IASLC). 

All other presenters, planners, editors, or staff report no relationshops to disclose:

"I do not have at present nor have had within the last 24 months, any financial relationships with ineligible companies."

Accreditation Statement: 
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Association for the Study of Lung Cancer is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statements:

The International Association for the Study of Lung Cancer designates the live or enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Registered Nurses
For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education).

Physician Assistants
The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification.

International CPD Credit Reciprocity Agreements

The Royal College will recognize the number of participation hours as MOC Program Section 1 accredited group learning credits for group learning activities developed by Accreditation Council for Continuing Medical Education (ACCME)-accredited physician organizations (university, academy, specialty society, hospital department etc.) that are held within and outside of Canada. Agreement dates: November 1, 2019 to December 31, 2025.

European Union
The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 credit™ into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

The American Medical Association (AMA) and the Department of Healthcare Professions–Accreditation Section (DHP-AS), Ministry of Public Health–Qatar have renewed their CME agreement under which select activities approved for AMA PRA Category 1 Credit™ are eligible for conversion of the hours of participation to Department of Healthcare Professions Continuing Professional Development (DHP-CPD) credit. This agreement is in place through Dec. 31, 2026.
The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; participants should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:
  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out, if applicable.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test.
  4. Complete the activity evaluation to provide feedback for future programming and receive credit.
You may now view or print the certificate from your CME/CE Transcript. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Transcript and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Transcript.

*The credit that you receive is based on your membership profile.
If you need assistance with this activity, please email: education@iaslc.org.
Powered By